These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16896285)

  • 21. Challenges and opportunities in SLE clinical trials.
    van Vollenhoven RF
    Curr Opin Rheumatol; 2013 Sep; 25(5):606-15. PubMed ID: 23917158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of antimalarials in systemic lupus erythematosus.
    Nayak V; Esdaile JM
    Lupus; 1996 Jun; 5 Suppl 1():S23-7. PubMed ID: 8803906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SiLEncing SLE: the power and promise of small noncoding RNAs.
    Rigby RJ; Vinuesa CG
    Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learned from clinical trials in SLE.
    Strand V
    Autoimmun Rev; 2007 Mar; 6(4):209-14. PubMed ID: 17317609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials for lupus--are we there yet?
    Merrill JT
    Bull NYU Hosp Jt Dis; 2009; 67(3):267-70. PubMed ID: 19852748
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on emerging drug therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):53-70. PubMed ID: 20148712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Better conduct of clinical trials: the control group in critical care trials.
    Takala J
    Crit Care Med; 2009 Jan; 37(1 Suppl):S80-90. PubMed ID: 19104230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic lupus erythematosus and pregnancy.
    Molad Y
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):613-7. PubMed ID: 17099331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLE - hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor AE
    Arthritis Res Ther; 2003; 5(5):207-9. PubMed ID: 12932278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials and the evaluation of new periodontitis therapies.
    Paquette DW; Fiorellini JP
    Curr Opin Periodontol; 1994; ():87-98. PubMed ID: 8032470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New therapies in systemic lupus erythematosus.
    Solsky MA; Wallace DJ
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):293-312. PubMed ID: 12041955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma exchange for systemic lupus erythematosus.
    Pagnoux C
    Transfus Apher Sci; 2007 Apr; 36(2):187-93. PubMed ID: 17368988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.
    Costenbader KH; Karlson EW; Gall V; de Pablo P; Finckh A; Lynch M; Bermas B; Schur PH; Liang MH
    Arthritis Rheum; 2005 Oct; 53(5):718-23. PubMed ID: 16208639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
    Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.
    Schiffenbauer J; Hahn B; Weisman MH; Simon LS
    Arthritis Rheum; 2004 Aug; 50(8):2415-22. PubMed ID: 15334452
    [No Abstract]   [Full Text] [Related]  

  • 40. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.